CG2YYZZ
Tomographic (Tomo) Nuclear Medicine Imaging Endocrine System to None with None, Other Radionuclide Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | C Nuclear Medicine |
| Body System | G Endocrine System |
| Operation | 2 Tomographic (Tomo) Nuclear Medicine Imaging |
| Body Part | Y Endocrine System |
| Approach | Y Other Radionuclide |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Introduction of radioactive materials into the body for three dimensional display of images developed from the capture of radioactive emissions
Procedure Overview
This family covers three-dimensional, rotational nuclear medicine scans of endocrine organs, most notably SPECT or SPECT/CT parathyroid localization and MIBG scanning of the adrenal glands. The gamma camera circles the patient to build a stack of cross-sectional slices, giving much sharper anatomic detail than a flat scan and allowing a small overactive gland to be pinpointed relative to surrounding structures.
Surgeons commonly request a parathyroid SPECT/CT before minimally invasive parathyroidectomy so they know exactly which of the four glands to remove. Adrenal MIBG scans, using an iodine-labeled tracer taken up by adrenal medullary tissue, help detect or stage a pheochromocytoma or neuroblastoma. These studies take longer than a basic planar scan because of the additional rotational acquisition time and post-processing needed to reconstruct the images.
Anatomy & Axis Detail
Endocrine System
Applying tomographic technique broadly across the endocrine system allows three-dimensional localization of abnormal uptake foci wherever they arise among the hormone-producing glands, which matters most when disease is suspected to involve multiple sites or when a lesion's precise anatomic relationship to surrounding structures needs clarification beyond what flat projections provide. This is particularly relevant for neuroendocrine tumors or metastatic disease that can occur at scattered locations from the neck through the abdomen, where cross-sectional imaging, often fused with CT, helps distinguish a true endocrine focus from overlapping bowel, vascular, or skeletal activity. Because the endocrine glands differ so much in depth and surrounding anatomy, this system-wide tomographic approach is reserved for cases where localization precision across multiple possible sites outweighs the added complexity compared with a single-gland study.
Radionuclide: Other Radionuclide
Other Radionuclide is used when a nuclear medicine study employs a radioactive tracer that does not correspond to one of the specifically named isotope values in this axis, such as an uncommon or newer radiopharmaceutical. It functions as a catch-all so the procedure can still be coded precisely by section and root operation even when the exact tracer lacks its own dedicated code value.
Coding & Documentation
The medical record must describe a rotational, multi-angle acquisition reconstructed into cross-sectional or three-dimensional images, ideally with the SPECT or SPECT/CT protocol named explicitly. Documentation of fused CT anatomy strengthens the case for this code but is not required if SPECT alone was performed. The most common coding pitfall is treating any parathyroid scan with delayed imaging as tomographic; many protocols are actually dual-phase planar studies with an early and late flat image, and the word "tomographic" appears nowhere in the technologist's actual acquisition parameters, only in loose radiologist phrasing.
Commonly Confused With
This family is most often mixed up with Planar Nuclear Medicine Imaging of the endocrine system, where the difference hinges entirely on whether cross-sectional reconstruction occurred. It can also be confused with therapeutic radiopharmaceutical administration, such as high-dose I-131 treatment for thyroid cancer, which is a treatment procedure in a different section rather than a diagnostic imaging study.